01 2Aspen Pharmacare Holdings
02 1Cohance Lifesciences
03 4Alfred E Tiefenbacher GmbH
04 2ANGITA PHARMA INC.
05 3Actavis Inc
06 2Adcock Ingram
07 2Adelco-Chromatourgia Anthinon E. Colocotronis Bros S.A.
08 5Alembic Pharmaceuticals Limited
09 4Alphapharm PTY Ltd
10 2Anchen Pharmaceutical, Inc
11 6Apotex Inc
12 4Arrow Pharmaceuticals
13 2Ascent Innovative Medicines
14 2Aspire Lifesciences Pvt Ltd
15 2Cipla Medpro South Africa
16 2Eurofarma Laboratorios S.A
17 4Generic Health
18 3Hikma Pharmaceuticals
19 2INNOVATA PHARMACEUTICALS
20 2JAMP PHARMA
21 1Jivita Health Care
22 2LABORATORIOS NORMON SA
23 3Lupin Ltd
24 2MEDICAP LABS
25 2Macleods Pharmaceuticals Limited
26 2Neuraxpharm
27 2Osmotica Pharmaceuticals
28 2PHARMOBEDIENT
29 2PRO DOC LIMITEE
30 4Pfizer Consumer Healthcare
31 11Pfizer Inc
32 2Pharma Dynamics
33 2Precise Group
34 3Rubicon Research
35 2SANIS HEALTH INC
36 2SIVEM PHARMACEUTICALS ULC
37 10Sandoz B2B
38 2Taro Pharmaceutical Industries
39 2Teva Pharmaceutical Industries
40 4WAGNER PHARMACEUTICALS PTY LTD
41 2Waymade
42 5Yichang Humanwell Pharmaceutical
43 3Zydus Pharmaceuticals
44 2Blank
01 4Coated Tablet
02 3ER Tablet
03 2Extended Release Tablet
04 6Extended-Release Tablet
05 2FCT
06 2Granules
07 2Modified Release Tablet
08 4Prolonged Release tablet
09 4Prolonged-Release Tablet
10 1Sustain Release Pellet
11 10TAB
12 20TABLET (EXTENDED-RELEASE)
13 36TABLET, EXTENDED RELEASE;ORAL
14 2Tablet
15 32Blank
01 2Allowed
02 4Authorised
03 4Authorized
04 2Cancelled
05 4DISCN
06 4EU Dossier Readiness-Q1 2020
07 12Generic
08 2Originator
09 20Prescription
10 30RX
11 46Blank
01 2AG-DESVENLAFAXINE
02 2APO-DESVENLAFAXINE
03 4APO-Desvenlafaxine MR
04 4BTC Desvenlafaxine
05 4DESVEN
06 10DESVENLAFAXINE
07 27DESVENLAFAXINE SUCCINATE
08 4DESVENLAFAXINE-WGR XR
09 1Depven 100 XL
10 1Depven 50 XL
11 4Desfax
12 2Deslafeks
13 1Deslafore XR 100
14 1Deslafore XR 50
15 2Desveneurax
16 4Desvenlafaxine GH XR
17 4Desvenlafaxine Sandoz
18 2Desvenlafaxine Waymade
19 2Desvenlafaxine/Adelco
20 2Desvenlafazine Normon
21 2Enzude
22 1Exlov XR 100 mg
23 1Exlov XR 50 mg
24 1Exsira 100mg
25 1Exsira 50mg
26 2JAMP DESVENLAFAXINE
27 2KHEDEZLA
28 5PRISTIQ
29 6Pristiq
30 2SANDOZ DESVENLAFAXINE
31 2TARO-DESVENLAFAXINE
32 2TEVA-DESVENLAFAXINE
33 1Voloxin 100mg
34 1Voloxin 50mg
35 18Blank
01 32Australia
02 4Brazil
03 20Canada
04 2China
05 4Germany
06 8India
07 4Malta
08 12South Africa
09 6Spain
10 2Switzerland
11 36USA
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Voloxin 50mg
Dosage Form : TAB
Dosage Strength : 50mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Pellet
Dosage Strength : 41.38%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Voloxin 100mg
Dosage Form : TAB
Dosage Strength : 100mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2018-09-14
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 204009
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 204009
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2008-02-29
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2008-02-29
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2014-08-20
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2017-10-11
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2017-10-11
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2022-11-30
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
